PHSE
Pharmhouse Corp
0.0099$
+23.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 2014 | 2015 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 100.0% | |
| 53.7% | 59.9% | 75.1% | 22.3% | 0.1% | 100.7% | 74.3% | – | – | – | – | – | – | 22.3% | |
| 46.3% | 40.1% | 24.9% | 77.7% | 0.0% | -0.7% | 25.7% | – | – | – | – | – | – | 77.7% | |
| 16.5% | 18.6% | 16.3% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | 52.6% | 0.0% | – | – | – | – | – | – | – | – | 378.8% | |
| 55.9% | 60.2% | 66.6% | 54.1% | 0.0% | 24.3% | 56.4% | – | – | – | – | – | – | 378.8% | |
| -9.6% | -20.1% | -41.7% | 23.6% | -24.2% | -25.0% | -30.9% | – | – | – | – | – | – | -301.1% | |
| 1.9% | 2.4% | 5.4% | – | – | 5.9% | 8.8% | – | – | – | – | – | – | 2.1% | |
| -10.9% | -22.0% | -43.0% | 6.7% | -29.5% | -30.9% | -39.6% | – | – | – | – | – | – | -301.6% | |
| -3.7% | -0.4% | 0.0% | – | 1.0% | 0.1% | 0.2% | – | – | – | – | – | – | – | |
| -7.2% | -21.6% | -43.0% | 6.7% | 0.0% | -30.9% | -39.6% | – | – | – | – | – | – | -312.0% | |
| -6.5% | -16.5% | -33.5% | 19.0% | -24.2% | -10.0% | -15.7% | – | – | – | – | – | – | -301.1% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.